Hillevax Correlations
HLVX Stock | USD 1.96 0.03 1.55% |
The current 90-days correlation between Hillevax and Pmv Pharmaceuticals is 0.1 (i.e., Average diversification). The correlation of Hillevax is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Hillevax Correlation With Market
Weak diversification
The correlation between Hillevax and DJI is 0.36 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Hillevax and DJI in the same portfolio, assuming nothing else is changed.
Hillevax |
Moving together with Hillevax Stock
0.65 | VANI | Vivani Medical | PairCorr |
0.61 | VCEL | Vericel Corp Ord | PairCorr |
0.68 | VCYT | Veracyte | PairCorr |
0.64 | VERA | Vera Therapeutics | PairCorr |
0.71 | DRUG | Bright Minds Biosciences Trending | PairCorr |
0.61 | DSGN | Design Therapeutics | PairCorr |
0.62 | SABSW | SAB Biotherapeutics | PairCorr |
0.74 | DVAX | Dynavax Technologies | PairCorr |
0.71 | VRNA | Verona Pharma PLC | PairCorr |
0.71 | VSTM | Verastem Trending | PairCorr |
Moving against Hillevax Stock
0.64 | DOMH | Dominari Holdings | PairCorr |
0.59 | ME | 23Andme Holding | PairCorr |
0.52 | VALN | Valneva SE ADR | PairCorr |
0.35 | DRRX | Durect | PairCorr |
0.33 | A | Agilent Technologies | PairCorr |
0.33 | DRMA | Dermata Therapeutics | PairCorr |
0.58 | VIRX | Viracta Therapeutics | PairCorr |
0.57 | VINC | Vincerx Pharma | PairCorr |
0.52 | DTIL | Precision BioSciences Downward Rally | PairCorr |
0.46 | VRCA | Verrica Pharmaceuticals | PairCorr |
0.45 | CDTTW | Conduit Pharmaceuticals | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Hillevax Stock performing well and Hillevax Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Hillevax's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
PMVP | 1.63 | 0.04 | (0.01) | 0.20 | 1.98 | 4.32 | 13.98 | |||
ELYM | 3.90 | (0.89) | 0.00 | (2.24) | 0.00 | 6.21 | 34.87 | |||
MNOV | 5.04 | 1.48 | 0.21 | (0.49) | 4.08 | 14.50 | 61.30 | |||
PHVS | 3.09 | 0.04 | 0.03 | 0.14 | 3.78 | 7.76 | 21.41 | |||
PEPG | 3.40 | (0.69) | 0.00 | (0.38) | 0.00 | 6.69 | 26.81 | |||
MOLN | 4.47 | (0.21) | 0.00 | (0.04) | 0.00 | 9.38 | 52.92 | |||
GLUE | 5.20 | 0.88 | 0.25 | 0.41 | 3.74 | 8.10 | 102.66 | |||
TRDA | 2.26 | 0.02 | 0.05 | 0.12 | 2.94 | 5.70 | 16.14 | |||
VIGL | 3.30 | (0.49) | 0.00 | (0.64) | 0.00 | 7.39 | 37.50 | |||
IPSC | 3.87 | (0.23) | (0.01) | 0.03 | 4.25 | 7.44 | 21.67 |
Hillevax Corporate Management
Anju Chatterji | VP Operations | Profile | |
Kaia Agarwal | VP Affairs | Profile | |
Astrid MD | Chief Officer | Profile | |
Sean McLoughlin | Chief Officer | Profile | |
Paul JD | Secretary Counsel | Profile | |
Ozzie Berger | Senior Affairs | Profile |